Eric Schwartz's most recent trade in Integra Lifesciences Holdings Corp was a trade of 1,538 Common Stock done at an average price of $23.9 . Disclosure was reported to the exchange on March 11, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.95 per share. | 11 Mar 2025 | 1,538 | 57,200 (0%) | 0% | 23.9 | 36,835 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.95 per share. | 11 Mar 2025 | 1,180 | 56,020 (0%) | 0% | 24.0 | 28,261 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.61 per share. | 10 Mar 2025 | 773 | 58,738 (0%) | 0% | 22.6 | 17,478 | Common Stock |
Aveanna Healthcare Holding... | Erica Schwartz G. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 28,261 | 257,498 | - | 0 | Common Stock, par value $0.01 per share | |
Integra Lifesciences Holdi... | Schwartz I. Eric | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 24.60 per share. | 03 Dec 2024 | 4,070 | 59,511 (0%) | 0% | 24.6 | 100,102 | Common Stock |
Butterfly Network Inc - Or... | Erica Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 157,894 | 295,818 | - | 0 | Class A Common Stock | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 17,890 | 17,890 | - | - | Non- Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 8,283 | 65,019 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 7,745 | 56,736 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.22 per share. | 11 Mar 2024 | 1,371 | 48,991 (0%) | 0% | 36.2 | 49,658 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.88 per share. | 11 Mar 2024 | 1,090 | 63,929 (0%) | 0% | 35.9 | 39,109 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.88 per share. | 11 Mar 2024 | 348 | 63,581 (0%) | 0% | 35.9 | 12,486 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.73 per share. | 10 Mar 2024 | 799 | 50,362 (0%) | 0% | 36.7 | 29,347 | Common Stock |
Aveanna Healthcare Holding... | Schwartz Erica | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 53,942 | 229,237 | - | 0 | Common Stock, par value $0.01 per share | |
Integra Lifesciences Holdi... | Eric Schwartz I. | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 2,564 | 51,161 (0%) | 0% | 0 | Common Stock | |
Aveanna Healthcare Holding... | Schwartz Erica | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 103,175 | 0 | - | - | Restricted Stock Units | |
Aveanna Healthcare Holding... | Erica Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 103,175 | 175,295 | - | - | Common Stock | |
Aveanna Healthcare Holding... | Erica Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 61,611 | 0 | - | - | Restricted Stock Units | |
Aveanna Healthcare Holding... | Erica Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 61,611 | 72,120 | - | - | Common Stock | |
Butterfly Network Inc - Or... | Erica Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 65,789 | 137,924 | - | 0 | Class A Common Stock | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Purchase of securities on an exchange or from another person at price $ 37.89 per share. | 01 Jun 2023 | 2,640 | 48,597 (0%) | 0% | 37.9 | 100,035 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 12,419 | 12,419 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 5,070 | 52,222 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 2,393 | 49,829 (0%) | 0% | 52.9 | 126,518 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 1,371 | 48,458 (0%) | 0% | 52.9 | 72,485 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.61 per share. | 10 Mar 2023 | 915 | 46,373 (0%) | 0% | 52.6 | 48,138 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 594 | 47,864 (0%) | 0% | 52.9 | 31,405 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.61 per share. | 10 Mar 2023 | 416 | 45,957 (0%) | 0% | 62.6 | 26,046 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 338 | 47,288 (0%) | 0% | 52.9 | 17,870 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 238 | 47,626 (0%) | 0% | 52.9 | 12,583 | Common Stock |
Aveanna Healthcare Holding... | Erica Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 103,175 | 103,175 | - | - | Restricted Stock Units | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 5,641 | 47,152 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 2,156 | 39,551 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 1,400 | 41,511 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 560 | 40,111 (0%) | 0% | 0 | Common Stock | |
Clorox Co. | Eric Sean Schwartz | SVP - Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 144.00 per share. | 13 Sep 2022 | 1,143 | 4,501 (0%) | 0% | 144 | 164,592 | Common Stock |
Clorox Co. | Eric Sean Schwartz | SVP - Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 144.00 per share. | 13 Sep 2022 | 212 | 4,248 (0%) | 0% | 144 | 30,528 | Common Stock |
Clorox Co. | Eric Sean Schwartz | SVP - Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 144.00 per share. | 13 Sep 2022 | 41 | 4,460 (0%) | 0% | 144 | 5,904 | Common Stock |
Aveanna Healthcare Holding... | Erica Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2022 | 61,611 | 61,611 | - | - | Restricted Stock Units | |
Clorox Co. | Eric Sean Schwartz | SVP - Chief Marketing Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 148.61 per share. | 15 Jul 2022 | 873 | 3,303 (0%) | 0% | 148.6 | 129,737 | Common Stock |
Aveanna Healthcare Holding... | Erica Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2022 | 10,509 | 0 | - | - | Restricted Stock Units | |
Aveanna Healthcare Holding... | Erica Schwartz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2022 | 10,509 | 10,509 | - | - | Common Stock | |
Butterfly Network Inc - Or... | Erica Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 48,231 | 72,135 | - | 0 | Class A Common Stock | |
Infinity Pharmaceuticals Inc. | Brian Eric Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option(right to buy) | |
Infinity Pharmaceuticals Inc. | Brian Eric Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.68 per share. | 16 Jun 2022 | 30,919 | 30,919 (0%) | 0% | 0.7 | 20,994 | Common Stock |
Clorox Co. | Eric Sean Schwartz | SVP - Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 1,938 | 1,938 | - | - | Stock Option (Right to Buy) | |
Clorox Co. | Eric Sean Schwartz | SVP - Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 127.62 per share. | 14 Mar 2022 | 313 | 4,029 (0%) | 0% | 127.6 | 39,945 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 11 Mar 2022 | 27,539 | 27,539 | - | - | Non-Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 9,792 | 41,704 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 1,488 | 37,395 (0%) | 0% | 65.1 | 96,884 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 873 | 40,613 (0%) | 0% | 65.1 | 56,841 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 691 | 38,883 (0%) | 0% | 65.1 | 44,991 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 404 | 39,860 (0%) | 0% | 65.1 | 26,304 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 349 | 40,264 (0%) | 0% | 65.1 | 22,723 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 286 | 39,574 (0%) | 0% | 65.1 | 18,621 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 218 | 41,486 (0%) | 0% | 65.1 | 14,194 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.32 per share. | 01 Mar 2022 | 1,712 | 31,912 (0%) | 0% | 66.3 | 113,540 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 4,454 | 33,624 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 3,565 | 29,170 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 2,520 | 25,605 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.69 per share. | 03 Dec 2021 | 2,414 | 23,085 (0%) | 0% | 62.7 | 151,334 | Common Stock |
Infinity Pharmaceuticals Inc. | Brian Eric Schwartz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2021 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 7,267 | 7,267 | - | - | Non- Qualified Stock Option (right to buy) | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 2,411 | 25,939 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 261 | 25,499 (0%) | 0% | 68.1 | 17,774 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 179 | 25,760 (0%) | 0% | 68.1 | 12,190 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 69.10 per share. | 02 Mar 2021 | 4,212 | 23,528 (0%) | 0% | 69.1 | 291,031 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Sale of securities on an exchange or to another person at price $ 69.52 per share. | 25 Feb 2021 | 2,288 | 29,409 (0%) | 0% | 69.5 | 159,062 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.43 per share. | 25 Feb 2021 | 1,669 | 27,740 (0%) | 0% | 69.4 | 115,879 | Common Stock |
Integra Lifesciences Holdi... | Eric I. Schwartz | EVP, Chief Legal Officer & Sec | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.92 per share. | 03 Dec 2020 | 1,515 | 31,697 (0%) | 0% | 54.9 | 83,204 | Common Stock |